The economics and uncertainties of drug development require successful
companies to demonstrate early evidence of their compounds’ clinical
efficacy and tolerance in humans. But what is the most efficient and
cost-effective way to reach this milestone? MDS Pharma Services’
Drug Development Programs provide the solution. The knowledge and
leadership of highly experienced scientists are leveraged to help clients
design and execute comprehensive development strategies. This
integrated service spans the research process for small and large molecule
drugs from Lead Identification through Clinical Proof-of-Concept—and all
the way into full clinical development.
Our team combines expertise in pharmacology, chemogenomics,
drug metabolism, pharmacokinetics, analytical chemistry, toxicology and
safety pharmacology, pharmaceutical formulation, biopharmaceutics,
bioanalysis, clinical pharmacology, all phases of clinical research,
regulatory strategy and submissions support.
